This trial is evaluating whether Venus Bliss will improve 1 primary outcome and 2 secondary outcomes in patients with Adipose Tissue Atrophy. Measurement will happen over the course of week 1.
This trial requires 60 total participants across 1 different treatment group
This trial involves a single treatment. Venus Bliss is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Signs of atrophy are a number of physical changes that include loss of muscle mass, enlargement of fat around the body, and a loss of fat tissue around the face and shoulders. These changes can be viewed in a body mass index and/or waist circumference ratio." - Anonymous Online Contributor
"The cause of atrophy in the brain is not known, but brain weight increases may be from growth hormones produced in the hypothalamus or from cellular hyperplasia in the basal ganglia.\n" - Anonymous Online Contributor
"It appears that atrophy can be reduced by lifestyle modifications and by orchiectomy. Atrophy is also a reliable outcome measurement that can be used in the management of men." - Anonymous Online Contributor
"Many people who are treated with laser-assisted resurfacing show no measurable improvement at 12-month follow-up in objective measures or subjective signs of facial rejuvenation. Subjective scores and patient satisfaction also do not change in people who are treated with a second laser-assisted resurfacing session. Findings from a recent study are inconsistent with current consensus that LA-RA is an effective face rejuvenation treatment. In combination with clinical experience, the objective and subjective findings of this pilot study do reinforce the growing literature on the lack of effectiveness of laser-assisted resurfacing as a face rejuvenation procedure." - Anonymous Online Contributor
"Atrophy of the substantia nigra can be demonstrated on cross-sectional imaging of the midbrain using T2-weighted and FLAIR sequences. Atrophy can also be demonstrated using MRI sequences such as 3D 3T MRI and in an elegant, and minimally invasive, imaging technique called high angular resolution T2*-weighted imaging." - Anonymous Online Contributor
"About 4.4 million individuals a year in the United States are diagnosed with Atrophy. This makes up about 22.9% of US adults. However, it's important to note that for males, the rate is much higher, and that the rate of Atrophy and Osteoporosis is very similar. If someone was to have both Atrophy and Osteoporosis, The National Osteoporosis Foundation estimates that it would happen every 8 years. This gives an estimate for both genders of about 8.7 million people a year in the United States." - Anonymous Online Contributor
"Individuals with atrophy have a higher mortality and disability rate and are two times more likely to be unemployed than those without atrophy. These people are more likely to live alone, have a higher heart rate, a lower body mass index, higher blood pressure, and they are more likely to need assistance from others after a stroke. It is important for clinicians to carefully consider the physical symptoms of atrophy and how to treat it for these patients." - Anonymous Online Contributor
"We have shown that atrophy is common, and patients on immunosuppressive therapy should be screened for atrophy. The magnitude of atrophy as well as the presence of visceral fat were independent risk factors predicting the occurrence of acute rejection. Results from a recent paper have important implications for the timing of elective steroid tapering in patients undergoing renal transplantation." - Anonymous Online Contributor
"Patients who received the venus Bliss product reported significant increases in QoL over placebo, especially by baseline. The Venus Bliss product appears to have beneficial effects for women with moderate to severe vulvar atrophy." - Anonymous Online Contributor
"Atrophy of the cornea has an autosomal-residual pattern in the family-of-inheritance: the parent who may be free of symptoms has no offspring with atrophy while a sibling who has atrophy has an increased probability of producing an offspring with atrophy. Such a pattern may be due to a common pathogenic factor shared by the parent and child, or to a common environmental effect on the child. In the latter case, the prevalence of atrophy might vary with location." - Anonymous Online Contributor
"There have not been other venus bliss trials and therefore it is difficult to predict if other studies will confirm this phenomenon. However, venus bliss can be experienced in other areas of the brain and other parts of the body." - Anonymous Online Contributor
"Many women who [take the drug] report experiencing varying degrees of venus effects, often resulting in moderate to severe effects. These side effects are manageable and have usually subsided after treatment ceases or [relapses]. The side effects of venus bliss can be minimized through appropriate dose adjustment on an individual’s basis. The common side effects of venus bliss are usually mild, reversible, and generally improve with the gradual cessation of use." - Anonymous Online Contributor